Showing results (71-80 of 348) with videos related to

Sort By:
Pageof 35
Molecular Endocrinology (Baltimore, Md.)|June 6, 2009
Histone-acetylated control of fibroblast growth factor receptor 2 intron 2 polymorphisms and isoform splicing in breast cancerXuegong Zhu, Sylvia L Asa, Shereen Ezzat
Molecular Endocrinology (Baltimore, Md.)|May 14, 2005
1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesivenessWei Liu, Sylvia L Asa, Shereen Ezzat
Nature Reviews. Cancer|March 25, 2006
Pathogenetic mechanisms in thyroid follicular-cell neoplasiaTetsuo Kondo, Shereen Ezzat, Sylvia L Asa
Molecular Endocrinology (Baltimore, Md.)|May 1, 2002
Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitaryShunJiang Yu, Sylvia L Asa, Shereen Ezzat
Endocrine Pathology|March 7, 2020
Silent corticotroph adenoma with multiple cysts: Pars intermedia tumor?Hiroshi Nishioka, Asao Hirano, Sylvia L Asa
Molecular Endocrinology (Baltimore, Md.)|March 8, 2007
Ikaros is regulated through multiple histone modifications and deoxyribonucleic acid methylation in the pituitaryXuegong Zhu, Sylvia L Asa, Shereen Ezzat
Endocrine Pathology|June 24, 2025
Extended Hormone Profiling Identifies a Wider Network of Duodenal Neuroendocrine Tumor SubtypesLuvy Delfin, Shereen Ezzat, Sylvia L Asa
Endocrine Pathology|October 31, 2003
Controversies in papillary microcarcinoma of the thyroidMonique Piersanti, Shereen Ezzat, Sylvia L Asa
Endocrine-Related Cancer|January 27, 2017
Pituitary acromegaly: not one diseaseSylvia L Asa, Walter Kucharczyk, Shereen Ezzat
Pageof 35